$Recro Pharma(REPH)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-05-16 AccNo: 0000935836-17-000251 Size: 57 KB 网页链接
$Recro Pharma(REPH)$ 内部交易: 2017-05-12,10% Owner,Stonepine Capital Management, ,卖出,510000普通股, $7.40
$Recro Pharma(REPH)$ 内部交易: 2017-05-11,10% Owner,Stonepine Capital Management, ,卖出,9000普通股, $7.96
$Recro Pharma(REPH)$ 内部交易: 2017-05-10,10% Owner,Stonepine Capital Management, ,卖出,7500普通股, $7.77
$Recro Pharma(REPH)$ 内部交易: 2017-05-09,10% Owner,Stonepine Capital Management, ,卖出,228129普通股, $7.64
$Recro Pharma(REPH)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-05-11 AccNo: 0001564590-17-010492 Size: 6 MB 网页链接
$Recro Pharma(REPH)$ 8-K - Current report Filed: 2017-05-11 AccNo: 0001193125-17-166581 Size: 90 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Recro Pharma(REPH)$ 8-K - Current report Filed: 2017-05-09 AccNo: 0001193125-17-163418 Size: 52 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Recro Pharma(REPH)$ CT ORDER - Confidential treatment order Filed: 2017-05-08 AccNo: 9999999997-17-005992 Size: 10 KB 网页链接
$Recro Pharma(REPH)$ 内部交易: 2017-05-04,10% Owner,Stonepine Capital Management, ,卖出,201160普通股, $7.69